NSE BSE
indoco remedies ltd. stock

INDOCO REMEDIES LTD. Share Price

- - (%)
- NSE: INDOCO

INDOCO REMEDIES LTD. Share Price Update

As of the latest trading session, INDOCO REMEDIES LTD. share price is currently at 322, which is up by 2.54 from its previous closing. Today, the stock has fluctuated between 316.70 and 324.30. Over the past year, INDOCO REMEDIES LTD. has achieved a return of -0.95 %. In the last month alone, the return has been 0.39 %. Read More...

INDOCO REMEDIES LTD. Performance

Day Range

Low316.70 High324.30
326.60

52 Week Range

Low 286.60 High 415.00
326.60

INDOCO REMEDIES LTD. Share Price

11677

532612

INDOCO

img img img img
No Data Available

Open Price

316.70

Prev. Close

319.45

Volume (Shares)

71385.00

Total traded value

233.14

Upper Circuit

383.30

Lower Circuit

255.60

Note: The current prices & values are delayed, Login to your account for live updates.

INDOCO REMEDIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 2967.24
PE Ratio (TTM) 25.91
Book Value / Share 122.21
Beta 0.84
ROE 14.64%
EPS (TTM) 11.70
Dividend Yield 0.46%
Net Profit Qtr (Cr) 37.56

INDOCO REMEDIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 435.14
Operating Expense 422.77
Net Profit 37.56
Net Profit Margin (%) 8.63
Earnings Per Share (EPS) 4.08
EBITDA 81.14
Effective Tax Rate (%) 19.22
Particulars DEC 2023 (Values in Cr)
Revenue 448.38
Operating Expense 416.76
Net Profit 20.01
Net Profit Margin (%) 4.46
Earnings Per Share (EPS) 2.17
EBITDA 60.01
Effective Tax Rate (%) 25.94
Particulars SEP 2023 (Values in Cr)
Revenue 465.24
Operating Expense 430.48
Net Profit 33.14
Net Profit Margin (%) 7.12
Earnings Per Share (EPS) 3.60
EBITDA 73.54
Effective Tax Rate (%) 24.73
Particulars JUN 2023 (Values in Cr)
Revenue 413.19
Operating Expense 387.61
Net Profit 25.94
Net Profit Margin (%) 6.27
Earnings Per Share (EPS) 2.81
EBITDA 63.32
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 428.05
Operating Expense 389.62
Net Profit 25.37
Net Profit Margin (%) 5.92
Earnings Per Share (EPS) 2.75
EBITDA 64.66
Effective Tax Rate (%) 33.81
Particulars MAR 2024 (Values in Cr)
Revenue 1761.95
Operating Expense 1657.62
Net Profit 116.64
Net Profit Margin (%) 6.61
Earnings Per Share (EPS) 12.66
EBITDA 278.02
Effective Tax Rate (%) 23.87
Particulars MAR 2023 (Values in Cr)
Revenue 1638.13
Operating Expense 1477.43
Net Profit 141.36
Net Profit Margin (%) 8.62
Earnings Per Share (EPS) 15.34
EBITDA 287.22
Effective Tax Rate (%) 26.21
Particulars MAR 2022 (Values in Cr)
Revenue 1502.70
Operating Expense 1305.81
Net Profit 154.52
Net Profit Margin (%) 10.28
Earnings Per Share (EPS) 16.77
EBITDA 329.32
Effective Tax Rate (%) 34.58
Particulars MAR 2021 (Values in Cr)
Revenue 1217.38
Operating Expense 1112.07
Net Profit 92.39
Net Profit Margin (%) 7.58
Earnings Per Share (EPS) 10.03
EBITDA 226.69
Effective Tax Rate (%) 29.66
Particulars MAR 2020 (Values in Cr)
Revenue 1079.39
Operating Expense 1079.72
Net Profit 24.25
Net Profit Margin (%) 2.24
Earnings Per Share (EPS) 2.63
EBITDA 125.77
Effective Tax Rate (%) 15.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 111.58
ROE % 14.72
ROCE % 16.74
Total Debt to Total Equity 0.30
EBITDA Margin 17.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 98.17
ROE % 18.50
ROCE % 22.08
Total Debt to Total Equity 0.31
EBITDA Margin 21.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.45
ROE % 12.85
ROCE % 15.06
Total Debt to Total Equity 0.36
EBITDA Margin 18.31
Particulars MAR 2020 (Values in Cr)
Book Value / Share 73.75
ROE % 3.60
ROCE % 5.60
Total Debt to Total Equity 0.42
EBITDA Margin 11.35
Particulars MAR 2019 (Values in Cr)
Book Value / Share 71.69
ROE % -0.43
ROCE % 1.15
Total Debt to Total Equity 0.43
EBITDA Margin 8.55
Particulars MAR 2023 (Values in Cr)
Book Value / Share 111.45
ROE % 14.64
ROCE % 16.66
Total Debt to Total Equity 0.31
EBITDA Margin 17.23
Particulars MAR 2022 (Values in Cr)
Book Value / Share 98.13
ROE % 18.47
ROCE % 22.05
Total Debt to Total Equity 0.31
EBITDA Margin 21.39
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.44
ROE % 12.75
ROCE % 14.99
Total Debt to Total Equity 0.36
EBITDA Margin 18.28
Particulars MAR 2020 (Values in Cr)
Book Value / Share 73.81
ROE % 3.62
ROCE % 5.61
Total Debt to Total Equity 0.42
EBITDA Margin 11.37
Particulars MAR 2019 (Values in Cr)
Book Value / Share 71.74
ROE % -0.42
ROCE % 1.15
Total Debt to Total Equity 0.43
EBITDA Margin 8.56
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 13.34
Total Assets 1658.19
Total Liabilities 1658.19
Total Equity 1028.24
Share Outstanding 92150355
Price to Book Ratio 2.92
Return on Assets (%) 8.57
Return on Capital (%) 10.59
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 19.77
Total Assets 1486.09
Total Liabilities 1486.09
Total Equity 904.64
Share Outstanding 92150355
Price to Book Ratio 3.84
Return on Assets (%) 10.41
Return on Capital (%) 13.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.33
Total Assets 1315.06
Total Liabilities 1315.06
Total Equity 768.99
Share Outstanding 92150355
Price to Book Ratio 3.46
Return on Assets (%) 7.07
Return on Capital (%) 9.05
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 37.93
Total Assets 1271.59
Total Liabilities 1271.59
Total Equity 679.56
Share Outstanding 92150355
Price to Book Ratio 2.84
Return on Assets (%) 1.89
Return on Capital (%) 2.73
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 36.26
Total Assets 1258.04
Total Liabilities 1258.04
Total Equity 660.62
Share Outstanding 92150355
Price to Book Ratio 2.83
Return on Assets (%) -0.23
Return on Capital (%) -0.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.39
Total Assets 1659.67
Total Liabilities 1659.67
Total Equity 1027.02
Share Outstanding 92150355
Price to Book Ratio 2.92
Return on Assets (%) 8.51
Return on Capital (%) 10.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 19.20
Total Assets 1487.56
Total Liabilities 1487.56
Total Equity 904.30
Share Outstanding 92150355
Price to Book Ratio 3.84
Return on Assets (%) 10.38
Return on Capital (%) 13.45
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.05
Total Assets 1316.56
Total Liabilities 1316.56
Total Equity 768.92
Share Outstanding 92150355
Price to Book Ratio 3.46
Return on Assets (%) 7.01
Return on Capital (%) 8.99
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 37.64
Total Assets 1272.31
Total Liabilities 1272.31
Total Equity 680.16
Share Outstanding 92150355
Price to Book Ratio 2.84
Return on Assets (%) 1.90
Return on Capital (%) 2.75
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 36.18
Total Assets 1258.29
Total Liabilities 1258.29
Total Equity 661.08
Share Outstanding 92150355
Price to Book Ratio 2.83
Return on Assets (%) -0.22
Return on Capital (%) -0.31
Particulars MAR 2023 (Values in Cr)
Net Income 192.79
Cash from Operations 240.49
Cash from Investing -208.17
Cash from Financing 22.80
Net change in Cash -6.53
Free Cash Flow 447.74
Particulars MAR 2022 (Values in Cr)
Net Income 236.57
Cash from Operations 214.90
Cash from Investing -121.40
Cash from Financing -44.37
Net change in Cash 8.04
Free Cash Flow 340.23
Particulars MAR 2021 (Values in Cr)
Net Income 131.99
Cash from Operations 101.94
Cash from Investing -66.69
Cash from Financing -29.87
Net change in Cash -14.34
Free Cash Flow 178.78
Particulars MAR 2020 (Values in Cr)
Net Income 28.57
Cash from Operations 126.60
Cash from Investing -55.93
Cash from Financing -63.94
Net change in Cash 2.96
Free Cash Flow 185.06
Particulars MAR 2019 (Values in Cr)
Net Income -9.31
Cash from Operations 135.65
Cash from Investing -103.75
Cash from Financing -16.14
Net change in Cash 12.21
Free Cash Flow 232.60
Particulars MAR 2023 (Values in Cr)
Net Income 191.59
Cash from Operations 236.97
Cash from Investing -205.31
Cash from Financing 22.80
Net change in Cash -6.91
Free Cash Flow 426.36
Particulars MAR 2022 (Values in Cr)
Net Income 236.23
Cash from Operations 214.53
Cash from Investing -121.41
Cash from Financing -44.36
Net change in Cash 7.77
Free Cash Flow 339.86
Particulars MAR 2021 (Values in Cr)
Net Income 131.35
Cash from Operations 101.92
Cash from Investing -66.69
Cash from Financing -29.82
Net change in Cash -14.35
Free Cash Flow 178.77
Particulars MAR 2020 (Values in Cr)
Net Income 28.70
Cash from Operations 126.57
Cash from Investing -55.94
Cash from Financing -63.94
Net change in Cash 2.76
Free Cash Flow 185.03
Particulars MAR 2019 (Values in Cr)
Net Income -9.24
Cash from Operations 135.75
Cash from Investing -103.75
Cash from Financing -16.14
Net change in Cash 12.23
Free Cash Flow 232.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
INDOCO REMEDIES LTD. 327.75 33.48 2.72 3021.27 286.50 / 416.95
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
INDOCO REMEDIES LTD. 327.75 28.01 2.68 3021.27 286.50 / 416.95
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 332.20
  • 26 Days 332.60
  • 10 Days 335.80
  • 50 Days 329.50
  • 12 Days 336.40
  • 100 Days 334.00
  • 20 Days 333.60
  • 200 Days 336.50
337.20
PIVOT
First Resistance 341.40
Second Resistance 346.20
Third Resistance 350.40
First Support 332.40
Second Support 328.20
Third Support 323.40
RSI 51.45
MACD 3.76
Commodity Channel Index (CCI) -49.11
ADX 42.62
Williams % R -91.81

Over 1 Month

down

0.39

Over 3 Months

down

-1.29

Over 6 Months

down

-14.21

Over 1 Year

down

-0.95

Over 3 Years

down

-9.36

Over 5 Years

down

15.60

INDOCO REMEDIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

INDOCO REMEDIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
22.72
Promoter Holdings
58.75
FII
1.47
DII
17.04
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Spa Holdings Pvt Ltd Shareholding of Promoter and Promoter Group 1.8335E7 19.89
Shanteri Investment Pvt Ltd Shareholding of Promoter and Promoter Group 1.5771755E7 17.11
Panandikar Aditi Milind Shareholding of Promoter and Promoter Group 5608500.0 6.08
Madhura Suresh Kare Shareholding of Promoter and Promoter Group 5209000.0 5.65
Kare Aruna Suresh Shareholding of Promoter and Promoter Group 4794714.0 5.2
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund Public Shareholding 4579483.0 4.97
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 4199230.0 4.56
Kare Suresh Govind Shareholding of Promoter and Promoter Group 4060408.0 4.4
Dsp Healthcare Fund Public Shareholding 2094411.0 2.27
Icici Prudential Smallcap Fund Public Shareholding 1645715.0 1.79
Franklin India Smaller Companies Fund Public Shareholding 1362700.0 1.48
Hdfc Trustee Company Ltd A/c Hdfc Capital Builder Value Fund Public Shareholding 1334669.0 1.45
Mangeshi Investment Private Limited Public Shareholding 1167300.0 1.27
Suresh Govind Kare (huf) (karta- Suresh Govind Kare) Shareholding of Promoter and Promoter Group 273500.0 0.3
Sharda Ramnath Kare Shareholding of Promoter and Promoter Group 32500.0 0.04
Pratima Ajit Vaidya Shareholding of Promoter and Promoter Group 26550.0 0.03
Rohan Anup Ramani Shareholding of Promoter and Promoter Group 7300.0 0.01
Mahika Milind Panandikar Shareholding of Promoter and Promoter Group 7800.0 0.01
Milind S Panandikar Shareholding of Promoter and Promoter Group 7500.0 0.01
Sudha M Pai Shareholding of Promoter and Promoter Group 10727.0 0.01
Megh Milind Panandikar Shareholding of Promoter and Promoter Group 13000.0 0.01
Ramnath Govind Kare Shareholding of Promoter and Promoter Group 2000.0 0.0

INDOCO REMEDIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-18 2.25 Final 2023-09-19 Equity shares 2022-09-14 1.5 Final 2022-09-15 Equity shares 2022-09-14 0.75 Special 2022-09-16 Equity shares 2021-09-17 1.5 Final 2021-09-21 Equity shares 2020-09-18 0.3 Final 2020-09-22 Equity shares 2019-08-22 0.3 Final 2019-08-26 Equity shares 2018-08-31 1.0 Final 2018-09-04 Equity shares 2017-07-31 1.6 Final 2017-08-02 Equity shares 2016-07-20 0.2 Final 2016-07-22 Equity shares 2016-03-17 1.4 Interim 2016-03-18 Equity shares 2015-07-21 1.6 Final 2015-07-23 Equity shares 2014-07-21 1.4 Final 2014-07-23 Equity shares 2013-07-19 1.1 Final 2013-07-23 Equity shares 2012-07-20 1.1 Final 2012-07-24 Equity shares 2011-07-19 8.0 Final 2011-07-21 Equity shares 2010-07-13 7.0 Final 2010-07-15 Equity shares 2009-09-09 2.0 Final 2009-09-11 Equity shares 2008-12-11 3.25 Interim 2008-12-12 Equity shares 2008-09-19 5.0 Final 2008-09-23 Equity shares 2007-12-13 6.5 Final 2007-12-15 Equity shares 2005-09-15 0.0 Final 2005-09-17 Equity shares
Ex-Date Ex-Bonus Ratio
2012-05-17 2012-05-17 1:2
Ex-Date Old FV NEW FV Record Date
2012-05-17 10.0 2.0 2012-05-19

Learn More About Stocks

About INDOCO REMEDIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by INDOCO REMEDIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Indoco Remedies Ltd?

Answer Field

The share price of Indoco Remedies Ltd for NSE is ₹ 322 and for BSE is ₹ 322.15.

What is the Market Cap of Indoco Remedies Ltd?

Answer Field

The market cap of Indoco Remedies Ltd for NSE is ₹ 29,67.24 Cr. and for BSE is ₹ 29,68.62 Cr. as of now.

What is the 52 Week High and Low of Indoco Remedies Ltd?

Answer Field

The 52 Week High and Low of Indoco Remedies Ltd for NSE is ₹ 415.00 and ₹ 286.60 and for BSE is ₹ 416.95 and ₹ 286.50.

How to Buy Indoco Remedies Ltd share?

Answer Field

You can trade in Indoco Remedies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Indoco Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -0.95%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader